Phathom Pharmaceuticals, Inc.

PHAT·NASDAQ·$11.10Share Price as of 11/2·$885MMarket Cap as of 11/2

Financials

10-QQ3 ended 09/30/2610/29/26 10-QQ2 ended 06/30/2607/30/26 10-QQ1 ended 03/31/2604/30/26 10-KFY 202502/26/26 10-QQ3 ended 09/30/2510/30/25

Disclosures

8-KCurrent report10/29/26 8-KCurrent report10/26/26 8-KCurrent report10/23/26 8-KCurrent report09/29/26 8-KCurrent report07/30/26

Prospectuses and Registrations

S-8Registration of securities for employees03/27/26 424B5Prospectus supplement01/08/26 424B5Prospectus supplement01/07/26 S-3ASRAutomatic shelf registration01/07/26 S-8Registration of securities for employees04/03/25

Proxies

DEF 14ADefinitive proxy04/07/26 DEFA14AAdditional proxy materials04/07/26 DEF 14ADefinitive proxy04/23/25 DEFA14AAdditional proxy materials04/23/25 DEF 14ADefinitive proxy04/12/24

Ownership

Form 4Insider transaction10/08/26 Form 4Insider transaction09/08/26 SC 13GBeneficial ownership07/29/26 SC 13G/ABeneficial ownership (amended)07/20/26 Form 4Insider transaction07/16/26

Other

ARSAnnual report to shareholders04/07/26 ARSAnnual report to shareholders04/23/25 UPLOADLetter from the SEC06/25/24 CORRESPCorrespondence with the SEC06/14/24 UPLOADLetter from the SEC06/06/24